Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

NAMS
NewAmsterdam Pharma Company N.V.
stock NASDAQ

At Close
Sep 22, 2026 3:59:55 PM EDT
23.34USD+3.366%(+0.76)2,851,531
20.08Bid   26.62Ask   6.54Spread
Pre-market
Sep 22, 2026 8:14:30 AM EDT
23.00USD+1.860%(+0.42)100
After-hours
Sep 18, 2026 4:43:30 PM EDT
22.49USD0.000%(0.00)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
NAMS Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
NAMS Specific Mentions
As of Sep 22, 2026 4:53:12 PM EDT (<1 min. ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
1 day ago • u/SPAC_Time • r/Spacstocks • newamsterdam_pharma_and_menarini_group_receive • Post Merger • T
NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) - NAMS NAMSW
sentiment 0.48
1 day ago • u/SPAC_Time • r/Spacstocks • newamsterdam_pharma_and_menarini_group_receive • Post Merger • T
NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) - NAMS NAMSW
sentiment 0.48


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC